More Business Wire
View Older Stories View Newer Stories-
nVent Completes Sale of Thermal Management Business
-
Rayonier Announces Tax Treatment of 2024 Dividends
-
GROWERS Revolutionizes Agriculture Loyalty Program Through Use of AI
-
Hecla Fourth Quarter and Full-Year 2024 Results Conference Call/Webcast and Virtual Investor Event
-
Motorola Solutions to Issue Fourth-Quarter and Full-Year 2024 Earnings Results on February 13
-
IF Bancorp, Inc. Announces Results for Second Quarter of Fiscal Year 2025
-
Chimera Investment Corporation Announces Date of Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
Rithm Capital Corp. Announces Treatment of 2024 Taxable Dividends
-
Moog Inc. to Present at TD Cowen’s 46th Annual Aerospace and Defense Conference
-
MetLife CEO and CFO to Speak at Bank of America Securities 2025 Financial Services Conference
-
PennyMac Financial Services, Inc. Reports Fourth Quarter and Full-Year 2024 Results
-
Boot Barn Holdings, Inc. Announces Third Quarter Fiscal Year 2025 Financial Results
-
CORRECTING and REPLACING Wesleyan Impact Partners Names Rev. Dr. Aleze M. Fulbright and Rev. William H. Lamar IV as Board Members
-
Biote Announces CEO Retirement and Succession Plan
-
First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETF
-
AM Best Affirms A+ (Superior) Rating and Revises Outlook to Positive for RLI Corp., RLI Insurance Co., Mt. Hawley Insurance Co. and Contractors Bonding and Insurance Co.
-
PCB Bancorp Declares Increased Quarterly Cash Dividend of $0.20 Per Common Share
-
Caduceus Capital Partners Adds Ryan McKindles as New Managing Partner
-
LCNB Corp. Reports Financial Results for the Three and Twelve Months Ended December 31, 2024
-
PCB Bancorp Reports Earnings for Q4 2024 and Full Year 2024
-
The Bancorp, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Guidance
-
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
-
Deckers Brands Reports Third Quarter Fiscal Year 2025 Financial Results
-
Atlassian Announces Second Quarter Fiscal Year 2025 Results
-
Yelp Announces Date of Fourth Quarter and Full Year 2024 Financial Results
-
Emerald Completes Refinancing and Upsizing of $515 Million Term Loan and Revolver Extension
-
National Storage Affiliates Trust Announces Date of its Fourth Quarter 2024 Earnings Release and Conference Call
-
Sprinklr Announces Appointments to Board of Directors
-
BrightSpire Capital Announces Tax Treatment of 2024 Dividends
-
Reynolds Consumer Products Declares Regular Quarterly Cash Dividend
-
Sandisk to Host Investor Day 2025
-
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Visa Fiscal First Quarter 2025 Financial Results
-
Shake Shack to Announce Fourth Quarter 2024 Financial Results on February 20, 2025
-
Roku to Announce Fourth Quarter 2024 Financial Results on Feb. 13, 2025
-
MP Materials Announces Date for Fourth Quarter 2024 Financial Results and Webcast
-
Five9 to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20, 2025
-
Media Advisory: FHLB Dallas and Hancock Whitney Bank Award $105K in Grants to Louisiana Nonprofits
-
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
-
Floor & Decor Holdings, Inc. Announces Fourth Quarter Fiscal 2024 Earnings Conference Call
-
AI-powered Analytics Platform, Unwrap, Secures Series A to Redefine Customer IntelligenceÂ
-
Conduent to Report Fourth-Quarter and Full-Year 2024 Financial Results on Feb. 12, 2025
-
Dropbox to Announce Fourth Quarter and Fiscal 2024 Earnings Results
-
KBRA Assigns Texas Tech University System RFS Bonds at AA+, Stable Outlook
-
Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
-
Intel Reports Fourth-Quarter and Full-Year 2024 Financial Results
-
SkyWest, Inc. Announces Fourth Quarter and Annual 2024 Profit
-
Arcturus Therapeutics to Present at Guggenheim Securities SMID Cap Biotech Conference
-
Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office
-
Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons
